AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Discover effective ways to increase your savings rate, helping you reach your financial goals faster.
22,326 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
MicroStrategy's crypto treasury, dubbed Strategy, remains substantially underwater as Saylor signals another bitcoin ...
Robinhood Chain goes live on mainnet, delivering Layer 2 scalability for tokenized assets and a suite of around-the-c...
A retiree keeping 90% of a $1.7M portfolio in cash faces about $39,000 a year in lost growth, underscoring the long-t...
SpaceX joins the Nasdaq-100, setting up a mechanical buy flow for index funds. Analysts estimate about $4.3 billion i...
Ramp’s billionaire ignores résumés as the startup emphasizes proven ability over pedigrees, tapping teens who built M...
A London court sentenced seven people for a $5.4 million crypto scam that used fake police branding to steal digital ...
A wave of roughly $150 billion in tax refunds could spark new crypto inflows. Analysts say even a modest portion movi...
ONEOK posted robust Q4 2025 results, boosting full-year EBITDA, trimming debt, and highlighting synergies from recent...
Trip.com Group delivered a strong Q4, with revenue up 21% and international growth outpacing domestic momentum. The q...
Gas prices across the U.S. rose by 11 cents per gallon, according to AAA, dampening consumer budgets as crude markets...
Bitcoin climbs toward a potential retest of $90,000, but a stubborn sell wall tied to trapped traders keeps gains lim...